KCMédical: what changed
KCMédical
Largest movements
- Cash +€15,094
up €15,094 (+111%), from €13,553 to €28,648
mainly Net result for the year (+€37,426) and Depreciation (+€11,056)
- Tangible fixed assets -€11,056
down €11,056 (-23.4%), from €47,326 to €36,270
- Deferred charges and accrued income +€4,739
up €4,739 (+16.9%), from €27,971 to €32,710
- Profit (loss) carried forward +€37,426
new in 2025: €37,426
- Other debts -€21,019
down €21,019 (-49.3%), from €42,665 to €21,646
- Tax, wage and social debts -€11,174
down €11,174 (-46.1%), from €24,264 to €13,090
- Accrued charges and deferred income +€4,450
up €4,450 (+25.1%), from €17,751 to €22,201
- Gross operating margin -€21,475
down €21,475 (-26.4%), from €81,330 to €59,855
- Taxes -€10,704
down €10,704 (-45.4%), from €23,594 to €12,890
- Depreciation +€3,042
up €3,042 (+38.0%), from €8,014 to €11,056
- Financial income +€1,604
up €1,604 (+39,506%), from €4 to €1,608
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €138,851 | €148,628 | +€9,777 | +7.0% |
| Fixed assets | 21/28 | €47,326 | €36,270 | -€11,056 | -23.4% |
| Tangible fixed assets | 22/27 | €47,326 | €36,270 | -€11,056 | -23.4% |
| Furniture and vehicles | 24 | €47,326 | €36,270 | -€11,056 | -23.4% |
| Current assets | 29/58 | €91,525 | €112,358 | +€20,833 | +22.8% |
| Current investments | 50/53 | €50,000 | €51,000 | +€1,000 | +2.0% |
| Cash at bank and in hand | 54/58 | €13,553 | €28,648 | +€15,094 | +111% |
| Deferred charges and accrued income | 490/1 | €27,971 | €32,710 | +€4,739 | +16.9% |
| Total equity and liabilities | 10/49 | €138,851 | €148,628 | +€9,777 | +7.0% |
| Equity | 10/15 | €53,695 | €91,120 | +€37,426 | +69.7% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Reserves | 13 | €49,695 | €49,695 | = | 0.0% |
| Distributable reserves | 133 | €49,695 | €49,695 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €37,426 | +€37,426 | |
| Amounts payable | 17/49 | €85,157 | €57,508 | -€27,649 | -32.5% |
| Amounts payable within one year | 42/48 | €67,406 | €35,307 | -€32,099 | -47.6% |
| Trade debts | 44 | €478 | €571 | +€94 | +19.6% |
| Suppliers | 440/4 | €478 | €571 | +€94 | +19.6% |
| Taxes, remuneration and social security | 45 | €24,264 | €13,090 | -€11,174 | -46.1% |
| Taxes | 450/3 | €24,264 | €13,090 | -€11,174 | -46.1% |
| Other amounts payable | 47/48 | €42,665 | €21,646 | -€21,019 | -49.3% |
| Accrued charges and deferred income | 492/3 | €17,751 | €22,201 | +€4,450 | +25.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,014 | €11,056 | +€3,042 | +38.0% |
| Gross operating margin | 9900 | €81,330 | €59,855 | -€21,475 | -26.4% |
| Operating profit (loss) | 9901 | €73,317 | €48,799 | -€24,517 | -33.4% |
| Financial income | 75/76B | €4 | €1,608 | +€1,604 | +39,506% |
| Recurring financial income | 75 | €4 | €1,608 | +€1,604 | +39,506% |
| Financial charges | 65/66B | €33 | €92 | +€59 | +182% |
| Recurring financial charges | 65 | €33 | €92 | +€59 | +182% |
| Profit (loss) for the period before taxes | 9903 | €73,288 | €50,316 | -€22,972 | -31.3% |
| Income taxes | 67/77 | €23,594 | €12,890 | -€10,704 | -45.4% |
| Profit (loss) for the period | 9904 | €49,695 | €37,426 | -€12,269 | -24.7% |
| Profit (loss) for the period to be appropriated | 9905 | €49,695 | €37,426 | -€12,269 | -24.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.